RELX Group plc - Company Profile
Powered by 
All the data and insights you need on RELX Group plc in one report.
$295
- Save hours of research time and resources with
our up-to-date RELX Group plc Strategy Report
- Understand RELX Group plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
RELX Group plc (Relx) is a provider of information and analytics services. The company provides scientific, technical, and medical information to scientists, academic institutions, research leaders and administrators, medical researchers, research institutions, corporations, and governments. It offers legal and business information to law firms and corporations. The company also offers risk management, identity management, fraud detection and prevention, credit risk decision-making, and compliance solutions. It caters its services under ScienceDirect, Scopus, Cell, and the Lancet brands. The company has a geographical presence across North America, the Middle East, Europe, and Asia Pacific. Relx is headquartered in London, the UK.
Headquarters
United Kingdom
Address
1-3 Strand, London, England, WC2N5JR
Website
www.relx.com
Telephone
44 20 71665660
No of Employees
34,675
Industry
Business and Consumer Services
Ticker Symbol & Exchange
REL (LON)
Revenue (2022)
$11.4B
7.1%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
9%
(2022 vs 2021)
Market Cap*
$82.0B
Net Profit Margin (2022)
XYZ
1.8%
(2022 vs 2021)
* As of and is in US$
RELX Group plc premium industry data and analytics
Products and Services
| Services | Brands |
|---|---|
| Insurance Solutions | The Lancet |
| Business Services | Mendeley |
| Government Solutions | SciVal |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | New Products/Services | In March, Elsevier introduced Scopus AI. |
| 2023 | New Products/Services | In December, LexisNexis Risk Solutions announced the availability of LexisNexis Risk Classifier to support the supplemental group life insurance market. |
| 2023 | Contracts/Agreements | In November, LexisNexis Risk Solutions announced a new alliance with Agenium to integrate data and analytics into the life insurance application process. |
Competitor Comparison
| Key Parameters | RELX Group plc | Thomson Reuters Corp | Wolters Kluwer N.V. | Verisk Analytics Inc | Fair Isaac Corp |
|---|---|---|---|---|---|
| Headquarters | United Kingdom | Canada | Netherlands | United States of America | United States of America |
| City | London | Toronto | Alphen Aan Den Rijn | Jersey City | Bozeman |
| State/Province | England | Ontario | - | New Jersey | Montana |
| No. of Employees | 34,675 | 25,600 | 21,056 | 7,500 | 3,485 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Paul Walker | Chairman | Executive Board | 2021 | 66 |
| Erik Engstrom | Director; Chief Executive Officer | Executive Board | 2009 | 60 |
| Nicholas Lawrence Luff | Chief Financial Officer; Director | Executive Board | 2014 | 56 |
| Jelena Sevo | Chief Strategy Officer | Senior Management | 2019 | - |
| Henry Udow | Chief Legal Officer; Company Secretary | Senior Management | 2018 | 67 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer